Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.40%
SPX
-0.09%
IXIC
+0.11%
FTSE
-0.46%
N225
+0.39%
AXJO
+0.04%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

BioMarin Pharmaceutical: Positioned for Growth Amid Market Optimism and Innovative Therapies

3 days ago
publisher logo
Cashu

Biomarin Pharmaceutical's Innovations Transforming Rare Disease Treatments and Patient Outcomes

11 days ago
publisher logo
Cashu

BioMarin Pharmaceutical Challenges the Viability of the Orphan Drug Model in Pharma Industry

12 days ago

Key Stats

Market Cap
10.43B
Dividend Yield
0.00%
P/E Ratio
19.92
EPS
2.25
Revenue
2.85B
Avg. Volume
1.58M

About

What does BMRN do?
BioMarin Pharmaceutical, headquartered in San Rafael, California, develops therapies for serious rare diseases and employs 3,401 people. Its products include Vimizim, Roctavian, and Voxzogo for various medical conditions.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
http://www.biomarin.com
Stocks
Health Care
bmrn
Biomarin Pharmaceutical
BMRN
-0.48 (-0.89%)
54.205
USD
At close at Jun 25, 18:36 UTC
Summary
News
Signals
Benchmarks
Financials